Microbicidal paint was used in the oncology unit of Northside Hospital Healthcare System facility in Cummings, ga., according to a case study on from Sherwin-Williams Paint Shield.
The microbicidal properties of the paint were attractive given the compromised immune system of the patient population.
Paint Shield is the first EPA-registered microbicidal paint and kills greater than 99.9 percent of Staph (Staphylococcus aureus), MRSA (Methicillin-resistant Staphylococcus aureus), E. coli (Escherichia coli), VRE (Vancomycinresistant Enterococcus faecalis) and Enterobacter aerogenes within two hours of exposure on the painted surface, according to the case study.
Site Selection Mistakes: What Not To Do
High-Performance EFCO Systems Shape MUSC's New Black River Medical Center
Heritage Valley Health System to Officially Affiliate with Alleghany Health Network
The Impact of Acoustics on Patient Privacy
Texas Behavioral Health Center in Dallas Opens with Ribon-Cutting Ceremony